Will Eli Lilly say “Jaypirca”?

Eli Lilly said “Jaypirca” 3 times on its Aug 5, 2026 call (FY26 Q2), and on 7 of its last 8 calls: 3, 6, 4, 2, 2, 0, 4, 3 times. As of Oct 23, 2026, no Kalshi or Polymarket mention market on Eli Lilly saying “Jaypirca” has settled yet. Parrot’s p for the next listing is 76% (from the transcript model), not a forecast.

76%from transcript modelNext: Earnings call, Oct 29, 2026 · counts: company speakers + operator
Counts
company speakers + operator
Market
90¢ Kalshi (may be delayed)
Updated

Where it was said

quotes of at most 25 words; select an appearance

Eli Lilly

Jaypirca

Probability
76% · n=0
Last calls
said in 7 of 8

Next listing counts: company speakers + operator

FY26 Q2 earnings call, Aug 5, 2026 · said 3 times (counts)

Open the appearance

Counts: company speakers + operator (not listed here; the usual rule)

3 counted (3 in prepared remarks, 0 in Q&A).

Dave Rickscompanyprepared · 3:19Hear it 3:13, Dave Ricks In transcript

…dosing once every eight weeks in atopic dermatitis, the EU approval for Jaypirca in CLL across all lines of therapy, a positive CHMP opinion in…

Lucas Montarcecompanyprepared · 8:57Hear it 8:56, Lucas Montarce In transcript

…percentage points in the specialty dermatology market since last year. In Oncology, Jaypirca had another strong quarter of growth, and worldwide sales increased 56% compared…

Every match in the transcript

FY26 Q1 earnings call, Apr 30, 2026 · said 4 times (counts)

Open the appearance

Counts: company speakers + operator (not listed here; the usual rule)

4 counted (4 in prepared remarks, 0 in Q&A).

Dave RickscompanypreparedIn transcript

…compared to Q1 2025. Our key products currently defined as Ebglyss, Inluriyo, Jaypirca, Kisunla, Mounjaro, Omvoh, and Zepbound grew by more than $7 billion. Within…

Dave RickscompanypreparedIn transcript

…milestones since our last earnings call, including positive phase III data for Jaypirca in combination with a time-limited regimen in adults with previously treated CLL.

Every match in the transcript

FY25 Q4 earnings call, Feb 4, 2026 · not said

Open the appearance

FY25 Q3 earnings call, Oct 30, 2025 · said 2 times (counts)

Open the appearance

Counts: company speakers + operator (not listed here; the usual rule)

2 counted (2 in prepared remarks, 0 in Q&A).

David RickscompanypreparedIn transcript

…for early symptomatic Alzheimer's disease. Positive results from Phase III trial of Jaypirca in treatment of naive CLL. Positive overall survival data for Verzenio in…

Every match in the transcript

FY25 Q2 earnings call, Aug 7, 2025 · said 2 times (counts)

Open the appearance

FY25 Q1 earnings call, May 1, 2025 · said 4 times (counts)

Open the appearance

FY24 Q4 earnings call, Feb 6, 2025 · said 6 times (counts)

Open the appearance

FY24 Q3 earnings call, Oct 30, 2024 · said 3 times (counts)

Open the appearance

Questions

How many times did Eli Lilly say “Jaypirca” on its last earnings call?
Eli Lilly said “Jaypirca” 3 times on its Aug 5, 2026 call (FY26 Q2), and on 7 of its last 8 calls: 3, 6, 4, 2, 2, 0, 4, 3 times.
Who has to say it for the market to count?
Under the next market's rule: company speakers + operator.

Cite parrot.markets, “Eli Lilly: ‘Jaypirca’ mention history”, as of Oct 23, 2026, https://parrot.markets/earnings/LLY/words/jaypirca (CC BY 4.0)

Agents: this page as TSV at /api/v1/word?entity=eli-lilly&word=jaypirca · quotes: /api/v1/quotes?entity=eli-lilly&word=… · columnar JSON in #parrot-data · llms.txt · MCP